Chemicals & Advanced Materials Global On demand · 24-48h

Global Dextranase Market Strategic Research Report

Global Dextranase Market Strategic Research Report
$3,500 USD
Market Research Reports
Strategic Research Report
Global Dextranase Market
$1672025
3.7%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Food Grade, Feed Grade

By Application: Feed, Beer, Sugar, Others

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Novozymes, Amano, Specialty Enzymes, Aumgene Biosciences, Dyadic Netherlands, EN Group, SunHY, Sunson, Vland Biotech Group, Shandong Longda Bio-Products, Yangshao Bo-Chemical, Shandong Jienuo Enzyme, Hunan Hong Ying Xiang Biochemistry, Shandong Sukahan Bio-Technology, Hunan Lerkam Blology, Youtell Biotechnology

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 130 pages
Market size 2025
$167
Million USD
Forecast CAGR
3.7%
2025-2032
Forecast 2032
$215.4
Projected
Области
5
Asia Pacific · Latin America · MEA · Europe · North America

Обзор

Scope of the Report

The global Dextranase market size is predicted to grow from US$ 167 million in 2025 to US$ 215 million in 2032; it is expected to grow at a CAGR of 3.7% from 2026 to 2032.

Dextranase is obtained through submerged fermentation with the use of Bacillus Lichenifomis strains; the enzyme is an endonuclease, loyal acting β- glucan 1, 3 and 1, 4 glycosidic bonds, produce three - 5 glucose units oligosaccharides and glucose. The product can effectively break downβ- glucan in wheat and cereals endosperm cell walls, in the beer brewing used to reduce the viscosity of wort and improve the filtration performance, improve malt dissolution rate, to prevent the beer cloudy, stable quality of beer. Product is pale yellow powder or brown liquid; temperature range in 30 -60 ℃, the optimum temperature range in 50 -55 ℃; Applicable PH range 4.8-7.5, the optimum PH range 6.0-6.5.

The global dextranase market is experiencing steady growth, driven by its expanding applications across various industries. Dextranase, an enzyme that breaks down dextran—a polysaccharide that can adversely affect product quality—is increasingly utilized in sectors such as food and beverage, pharmaceuticals, and biofuels. In the food industry, particularly in sugar production and brewing, dextranase improves product clarity and processing efficiency by hydrolyzing dextran, which can interfere with crystallization and fermentation processes. The pharmaceutical sector leverages dextranase to enhance drug formulations and delivery systems, while the biofuel industry benefits from its role in breaking down biomass materials to facilitate bioethanol production.

Regionally, the Asia-Pacific market is poised for significant growth due to rapid industrialization and the expansion of food and pharmaceutical industries in countries like China and India. North America and Europe continue to be substantial markets, supported by advanced healthcare infrastructures and a strong emphasis on research and development. Despite challenges such as high production costs and regulatory hurdles, ongoing advancements in biotechnology and enzyme engineering are enhancing the efficacy and cost-effectiveness of dextranase. These innovations, coupled with the rising demand for sustainable and efficient industrial processes, are expected to sustain the market's upward trajectory in the coming years.

This report presents a comprehensive overview of the global Dextranase market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Food Grade
  • Feed Grade

Segment by Application

  • Feed
  • Beer
  • Sugar
  • Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Dextranase market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Feed, Beer, Sugar evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Dextranase Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 3.7%
Regional growth momentum
Market share by segment
Key metrics
Base value
$167
2025
Forecast
$215.4
2032
CAGR
3.7%
2025–2032
Области
5
global
Key companies
NovozymesAmanoSpecialty EnzymesAumgene BiosciencesDyadic NetherlandsEN GroupSunHYSunson
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Food GradeFeed Grade
By Application
FeedBeerSugarOthers

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Food Grade
  • 3.1.3 Feed Grade
  • 3.1.4 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Feed
  • 4.1.3 Beer
  • 4.1.4 Sugar
  • 4.1.5 Others
  • 4.1.6 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Novozymes
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Amano
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Specialty Enzymes
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Aumgene Biosciences
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Dyadic Netherlands
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 EN Group
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 SunHY
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Sunson
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Vland Biotech Group
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Shandong Longda Bio-Products
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Yangshao Bo-Chemical
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 Shandong Jienuo Enzyme
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Hunan Hong Ying Xiang Biochemistry
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 Shandong Sukahan Bio-Technology
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 Hunan Lerkam Blology
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
  • 8.16 Youtell Biotechnology
  • 8.16.1 Company Overview
  • 8.16.2 Key Products & Segments
  • 8.16.3 Financial Performance (2023–2025)
  • 8.16.4 Business Strategy
  • 8.16.5 SWOT Analysis
  • 8.16.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

How big is the global Dextranase market?
The global Dextranase market is estimated at US$ 167 million in 2025 (base year) and is projected to reach US$ 215 million by 2032.
How fast is the Dextranase market expected to grow?
The market is expected to grow at a CAGR of 3.7% from 2026 to 2032, expanding from US$ 167 million in 2025 to US$ 215 million in 2032, roughly 1.3 times its base-year value.
What does the Dextranase market cover?
Dextranase is obtained through submerged fermentation with the use of Bacillus Lichenifomis strains; the enzyme is an endonuclease, loyal acting β- glucan 1, 3 and 1, 4 glycosidic bonds, produce three - 5 glucose units oligosaccharides and glucose. The product can effectively break downβ- glucan in wheat and cereals endosperm cell walls, in the beer brewing used to reduce the viscosity of wort and improve the filtration performance, improve malt dissolution rate, to prevent the beer cloudy, stable quality of beer.
What are the main segments of the Dextranase market by type?
By type, the market is segmented into Food Grade and Feed Grade.
Which applications drive demand in the Dextranase market?
Key applications covered include Feed, Beer, Sugar and Others.
Who are the key players in the Dextranase market?
Key players profiled include Novozymes, Amano, Specialty Enzymes, Aumgene Biosciences, Dyadic Netherlands, EN Group, SunHY and Sunson, among 16 companies covered in total.
Which regions and countries are covered for Dextranase?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What is driving growth in the Dextranase market?
The global dextranase market is experiencing steady growth, driven by its expanding applications across various industries.
What challenges does the Dextranase market face?
Despite challenges such as high production costs and regulatory hurdles, ongoing advancements in biotechnology and enzyme engineering are enhancing the efficacy and cost-effectiveness of dextranase.
Who should buy the Dextranase market report?
The report is intended for manufacturers and solution providers, distributors and end users in Feed, Beer and Sugar, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Dextranase market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from 3 500,00 $
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.